Menu
Enrolling by invitation NCT05799768

Ketogenic Diet in Rheumatoid Arthritis (RA)

No phase Interventional Rheumatoid Arthritis Inflammation Obesity Ketogenic Dieting

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Ketogenic diet.
Who it may be relevant to
Registry conditions: Rheumatoid Arthritis, Inflammation, Obesity, Ketogenic Dieting. Basic parameters: 18 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Ketogenic Diet Intervention in Patients With Rheumatoid Arthritis (RA): a Pilot Study

Overview

This is a 6-week ketogenic diet (KD) intervention where participants with rheumatoid arthritis (RA) will follow a KD plan, supervised and monitored by a dietician. Participants will be provided extensive educational and ongoing support on the KD, including personalized coaching with the ability to text a dietitian at any time and expect a response within 12 hours. Diet adherence and progress will be assessed daily using at-home blood ketone/glucose monitors, along with diet records. Participants will fill out health related questionnaires and undergo assessments of body composition, RA disease activity. This study also includes blood draws and fat biopsy of the abdominal region.

Interventions

  • Behavioral Ketogenic diet
    Ketogenic diet counseling

Primary outcome measures

  • hsCRP [Time frame: 6 weeks]
Secondary outcome measures (1)
  • DAS28-CRP [Time frame: 6 weeks]

Eligibility criteria

Inclusion criteria

  • Diagnosis of RA according to the ACR/EULAR 2010 criteria for RA.
  • On stable doses of DMARDs and/ or biological agents (≥ 2 months prior to study enrollment)

Exclusion criteria

  • Chronic inflammatory/ autoimmune disease other than RA (e.g. gout, inflammatory bowel disease such as Crohn's disease or ulcerative colitis, lupus, myositis, etc.)
  • Prednisone or other glucocorticoid use in the last 4 weeks (exception: intra-articular glucocorticoid injections)
  • Insulin use
  • Hospitalization in the 30 days prior to study enrollment
  • Acute or uncontrolled disease (e.g. cirrhosis, COPD, CKD)
  • Malignancy
  • Chronic infection (HIV, hep B/C, etc.)
  • Heavy drinking
  • On a ketogenic diet or exogenous ketone supplement (lses than 3 months prior to study enrollment)
  • Recent weight loss (>5% in the last 2 months)

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Basic science

Study locations

United States · 1 center
  • Oklahoma University Health Sciences Center — Oklahoma City

Identifiers

NCT: NCT05799768 · 2020H0090

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗